Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation
Authors:
- 1 September 2003
- journal article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 11 (9) , 568-574
Abstract
Although peripheral blood stem-cell transplantation (PBSCT) has assumed a growing role in the treatment of multiple myeloma, very few studies have examined the functional and quality-of-life changes experienced by myeloma patients in the transplant setting. Multiple myeloma is characterized by a range of debilitating physical and psychosocial symptoms. However, supportive care needs for patients with this disease are often overlooked or managed only episodically. The current study pilot-tested an interdisciplinary supportive care program designed to provide screening and identify patients at risk early in the course of care. Participants in this pilot project were 61 patients with hematological disorders, predominantly multiple myeloma (85.3%), evaluated during their initial workup. Mean time since diagnosis was 7.4 months. Participants were interviewed by an advanced-practice nurse and completed standardized measures of heath-related quality of life (SF-12), fatigue (POMS-Fatigue), nutritional risk (PG-SGA), pain (Brief Pain Inventory), emotional functioning (Hospital Anxiety and Depression Scale), and sexual concerns (FACIT). Results indicated that difficulties were prevalent across multiple functional domains; 61.4% of patients displayed significant nutritional deficits. Physical functioning was below age-adjusted national norms for 53.5%. Moderate-to-severe fatigue was reported by 39.0%, and one third experienced clinically significant levels of pain, impaired daily functioning associated with pain, and emotional distress. A similar proportion of respondents (33.9%) reported disrupted sexual functioning and difficulty with body image. Findings suggest that early, systematic screening is feasible in a busy transplant center. The prevalence of symptoms highlights the importance of providing screening and proactive intervention for multiple myeloma patients early in the course of treatment and even prior to beginning protocols for high-dose therapy and transplantation.Keywords
This publication has 44 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- NCCN Practice Guidelines for Cancer-Related Fatigue.2000
- Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.2000
- The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantationBone Marrow Transplantation, 1999
- The Swedish version of the patient-generated subjectiveglobal assessment of nutritional status: gastrointestinal vs urological cancersClinical Nutrition, 1999
- Health-Related Quality of Life 1 Year After Allogeneic or Autologous Stem-Cell Transplantation: A Prospective StudyJournal of Clinical Oncology, 1999
- A Multidimensional Measure of Fatigue for Use with Cancer PatientsCancer Practice, 1998
- A prospective study of the effects of high-dose chemotherapy and bone marrow transplantation on sexual function in the first year after transplantBone Marrow Transplantation, 1997
- Supportive nutrition to prevent cachexia and improve quality of life.1995
- The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy; A comparison with the fatigue experienced by healthy individualsCancer Nursing, 1994